Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophrenia [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating a kynurenine aminotransferase inhibitor in people with schizophrenia, with completed status and r…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Food Effect Study of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia [Phase 1]
Phase 1 trial assessing the food effect on pharmacokinetics of a once-weekly brexpiprazole formulation in schizophrenia. Results have been p…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Assessment of Physical Activity, Balance, Muscle Strength, and Cognitive Function in Patients Diagnosed With Schizophrenia
This completed clinical trial evaluated physical activity, balance, muscle strength, and cognitive function in individuals with schizophreni…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Impact of Caregiver Beliefs on Adherence to Antipsychotic Medications in Patients With Schizophrenia
A terminated clinical trial evaluated whether caregiver beliefs influence adherence to antipsychotic medications in patients with schizophre…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Effectiveness of Exercise Alone and tDCS+Exercise on Cognitive Function Improvement in Patients With Treatment Resistant Schizophrenia [NA]
A clinical trial evaluating whether exercise alone and transcranial direct current stimulation plus exercise can improve cognitive function …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia [Phase 3]
Phase 3 Journey Study results completed evaluating valbenazine as an adjunctive treatment for schizophrenia to assess its efficacy, safety, …
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: PQQ for Cognitive and Negative Symptoms [NA]
A clinical trial is evaluating pyrroloquinoline quinone (PQQ) for cognitive and negative symptoms in schizophrenia. The study is not yet rec…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder [Phase 2]
Phase 2 trial evaluating tirzepatide's effects on alcohol intake in adults with schizophrenia and alcohol use disorder; the study is current…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia [Phase 2]
This Phase 2 clinical trial update describes a study to assess adverse events, changes in disease activity, and pharmacokinetics of oral emr…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: My Coach Connect: An Automated Telephone-based Reporting System for Patients With Mental Illness [NA]
This trial update notes the completion of the study evaluating My Coach Connect, an automated telephone-based reporting system for patients …
-
FDA approval · 2026-02-09FDA Approved: OLANZAPINE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approved a supplemental application for olanzapine from Dr. Reddy's Laboratories Inc., updating the existing approval for this product.
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Memantine Augmentation of Targeted Cognitive Training in Schizophrenia [Phase 2, Phase 3]
A completed Phase 2/3 trial evaluating memantine added to targeted cognitive training for schizophrenia and schizoaffective disorder.
-
EMA approval · 2026-02-09EMA Authorised: Zypadhera (olanzapine pamoate) — CHEPLAPHARM Registration GmbH
EMA authorised Zypadhera, an olanzapine pamoate long-acting injectable, for schizophrenia, for CHEPLAPHARM Registration GmbH, decision date …
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: A Phase 2 Study to Evaluate the Efficacy and Safety of LY03020 in Acutely Psychotic Participants With Schizophrenia [Phase 2]
Phase 2 clinical trial update evaluating LY03020 for efficacy and safety in acutely psychotic participants with schizophrenia.
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Mindfulness-Based Therapy for Serious Mental Illness [NA]
An update on an ongoing clinical trial evaluating mindfulness-based therapy for serious mental illness, including schizophrenia, major depre…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Medical Phenotyping of NHS General Adult Psychiatry (GAP) Inpatients
University of Edinburgh is conducting a clinical trial on medical phenotyping in NHS General Adult Psychiatry inpatients and is currently re…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: CBT-CP for Veterans With SMI [NA]
This clinical trial update describes an ongoing study of CBT-CP (cognitive behavioral therapy for chronic pain) for veterans with serious me…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Multicentre Evaluation of Bucco-dental Health in Patients With Schizophrenia in Côte d'Or [NA]
A multicenter evaluation of bucco-dental health in patients with schizophrenia in Côte d'Or has completed, assessing dental health status in…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Anticholinergic Deprescription in Schizophrenia [Phase 4]
A Phase 4 clinical trial is evaluating anticholinergic deprescription strategies in individuals with schizophrenia or schizoaffective disord…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia [NA]
A clinical trial aiming to enhance prefrontal oscillations and working memory in individuals with early-course schizophrenia is currently re…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Evaluate the Efficacy of a Global Dental Health Promotion Program on Dental Hygiene in Patients With Schizophrenia. [NA]
A clinical trial evaluating a global dental health promotion program to improve dental hygiene in patients with schizophrenia has been termi…
-
FDA approval · 2026-02-09FDA Approved: OLANZAPINE — Supplemental Application (Dr. Reddy's Laboratories Ltd.)
FDA approved Dr. Reddy's Laboratories' supplemental application for olanzapine, confirming the approval of a generic olanzapine product.
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: CONNEX-3: A Study to Test Whether Iclepertin Improves Learning and Memory in People With Schizophrenia [Phase 3]
The Phase 3 CONNEX-3 trial evaluating Iclepertin for improving learning and memory in schizophrenia has completed and posted results.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective. [Phase 1]
Phase 1 clinical trial evaluating the combination of pharmacotherapy and cognitive behavioral therapy under a recovery framework. The trial …
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: C-Cog in Early Course Schizophrenia Study [Phase 4]
Phase 4 trial of C-Cog in early-course schizophrenia was terminated; results have been posted (2026-02-06).